vindesine has been researched along with Pyrexia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bedikian, AY; Bodey, GP; Gutterman, JU; Hersh, EM; Maroun, J; Valdivieso, M | 1 |
Fujii, M; Fukuoka, M; Furuse, K; Ikegami, H; Katakami, N; Nakai, Y; Nakajima, S; Negoro, S; Takada, Y; Yamori, S | 1 |
Mempel, K; Pfetsch, M; Reiter, A; Riehm, H; Schrappe, M; Schwab, G; Welte, K | 1 |
Bastion, Y; Bosly, A; Coiffier, B; Dabouz-Harrouche, F; Deconinck, E; Dupriez, B; Gisselbrecht, C; Haioun, C; Herbrecht, R; Lepage, E; Marit, G; Marolleau, JP; Reyes, F; Tilly, H; Yver, A | 1 |
3 trial(s) available for vindesine and Pyrexia
Article | Year |
---|---|
[A late phase-II trial comparing KW-2307 with vindesine in non-small cell lung cancer (1). Lung cancer section in KW-2307 Study Group].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Female; Fever; Humans; Injections, Intravenous; Leukopenia; Lung Neoplasms; Male; Middle Aged; Vinblastine; Vindesine; Vinorelbine | 1995 |
A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Münster Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Etoposide; Female; Fever; Filgrastim; Gastrointestinal Diseases; Germany; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Ifosfamide; Infant; Infection Control; Life Tables; Male; Mercaptopurine; Methotrexate; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prospective Studies; Recombinant Proteins; Risk; Survival Analysis; Thioguanine; Vincristine; Vindesine | 1996 |
Placebo-controlled phase III study of lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) in aggressive non-Hodgkin's lymphoma: factors influencing chemotherapy administration. Groupe d'Etude des Lymphomes de l'Adulte.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Fever; Granulocyte Colony-Stimulating Factor; Humans; Infections; Lenograstim; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Placebos; Recombinant Proteins; Survival Rate; Treatment Outcome; Vindesine | 1997 |
1 other study(ies) available for vindesine and Pyrexia
Article | Year |
---|---|
Evaluation of vindesine and MER in colorectal cancer.
Topics: Adult; Aged; Agranulocytosis; BCG Vaccine; Colonic Neoplasms; Drug Evaluation; Female; Fever; Humans; Immunotherapy; Injections, Intravenous; Male; Middle Aged; Peripheral Nervous System Diseases; Prognosis; Rectal Neoplasms; Thrombocytopenia; Vinblastine; Vindesine | 1980 |